Larvol Delta - Positive-Topline-Data-from-Phase-2a-ProofofConcept-Trial-of-EVO301-a-Novel-IL18-Binding-Protein-in-Patients-with-ModeratetoSevere-Atopic-Dermatitis

EVO301 - Evommune

https://pagv3.virtual-meeting.org/eadv/eadvcongress2026/en-GB/pag/presentation/63657

Mark G. Lebwohl

Aug 6, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next